Mark Franklyn Rosenberg works on two fronts: doing hands-on research while explaining science to others. His research focuses on structural biology and drug discovery, especially for cancer, cystic fibrosis, and Alzheimer's. His work in the lab relies on approaches such as cryo-EM, crystallization, structural analysis, immunology techniques, cell culture, and vaccine development.
Mark earned his PhD in Clinical Biochemistry from the University of Manchester and later became a Research Fellow at Imperial College London and a Senior Scientist at The University of Manchester. Though trained in biochemistry, he now works in structural biology, data science, and drug discovery. Mark has published over 40 papers and always focuses on making his findings understandable to people outside his specialty.
This guide explores fibroblast markers like PDGFRα, PDGFB, CD26, CD90 and FAP that can be detected with antibodies to identify distinct cell populations...
Adipocyte markers, such as AQP7, UCP1 and TMEM26 are used to differentiate white, brown, and beige adipocytes to study metabolic regulation of adipose tissue...
Explore markers such as cardiac troponins, myosin, GATA4, connexin-43, NKX2.5, and natriuretic peptides for identifying and characterizing cardiomyocytes...
